Treatment of iron-deficient conditions in case of inefficiency or impossibility of treatment with iron preparations for oral use.
Ferrum-Lek tablets Composition
active ingredient ferrum lek:
Ferrum-Lek tablets excipients ferrum lek:
MAIN PHYSICAL AND CHEMICAL PROPERTIES:
tablets are brown-white interspersed, round, flat, with beveled edges.
ATX code B03A B05.
Ferrum-Lek tablets Indications
Treatment of iron deficiency without anemia (latent iron deficiency) and iron deficiency anemia (clinically significant iron deficiency).
Iron deficiency and its degree must be confirmed by appropriate laboratory tests.
INTERACTION WITH OTHER DRUGS AND OTHER INTERACTIONS
Studies in rats using tetracycline, aluminum hydroxide, acetylsalicylic acid, sulfasalazine, calcium carbonate, calcium acetate, calcium phosphate in conjunction with vitamin D3, bromazepam, magnesium aspartate, D-penicillamine, methyldopa, paracetamol and Auranofin showed no interaction with the polymaltose complex ( iii) hydroxide.
The use of the drug Ferrum Lek does not affect the test results for detecting occult blood (sensitive to hemoglobin), so there is no need to stop treatment with Ferrum Lek.
FEATURES OF APPLICATION
Caution should be exercised in relation to patients receiving repeated blood transfusions, since erythrocytes already have an iron reserve, and taking the drug Ferrum Lek can lead to iron oversaturation.
When prescribing the drug Ferrum Lek for patients with diabetes mellitus, it is necessary to take into account that 1 chewable tablet contains 0.04 XE.
1 tablet contains 1.5 mg of aspartame (the precursor of phenylalanine), which should be taken into account when prescribing Ferrum Lek to patients with phenylketonuria.
Iron preparations should be used with caution in patients with such diseases: leukemia, chronic liver and kidney diseases, inflammatory diseases of the gastrointestinal tract, gastric ulcer and duodenal ulcer, bowel disease (enteritis, ulcerative colitis, Crohn’s disease).
When using a polymaltose iron complex, a dark color of feces is possible, but this has no clinical significance.
APPLICATION DURING PREGNANCY OR BREASTFEEDING
The use of the drug Ferrum Lek during pregnancy and lactation is recommended only after consultation with a doctor and a careful assessment of the benefit / risk ratio.
ABILITY TO INFLUENCE THE RATE OF REACTION WHEN DRIVING A VEHICLE OR OTHER MECHANISMS
Method of administration and dosage
The daily dose of the drug Ferrum Lek and the duration of treatment depend on the degree of iron deficiency.
The duration of treatment for latent iron deficiency without anemia is 1-2 months.
From the immune system: very rarely – allergic reactions.
From the nervous system: infrequently – headache.
Keep out of the reach of children.